Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. Tridello, G.
  4. Schwartz, J.
  5. Martinez-Cibrián, N.
  6. Barba, P.
  7. Kwon, M.
  8. Lopez-Corral, L.
  9. Martinez-Lopez, J.
  10. Ferra, C.
  11. Di Blasi, R.
  12. Ghesquieres, H.
  13. Mutsaers, P.
  14. Calkoen, F.
  15. Jak, M.
  16. van Doesum, J.
  17. Vermaat, J.S.P.
  18. van der Poel, M.
  19. Maertens, J.
  20. Gambella, M.
  21. Metafuni, E.
  22. Ciceri, F.
  23. Saccardi, R.
  24. Nicholson, E.
  25. Tholouli, E.
  26. Matthew, C.
  27. Potter, V.
  28. Bloor, A.
  29. Besley, C.
  30. Roddie, C.
  31. Wilson, K.
  32. Nagler, A.
  33. Campos, A.
  34. Petersen, S.L.
  35. Folber, F.
  36. Bader, P.
  37. Finke, J.
  38. Kroger, N.
  39. Knelange, N.
  40. de La Camara, R.
  41. Kersten, M.J.
  42. Mielke, S.
  43. Mostrar todos os autores +
Revista:
Leukemia

ISSN: 1476-5551,  0887-6924

Ano de publicación: 2024

Volume: 38

Número: 9

Páxinas: 1985-1991

Tipo: Artigo

DOI: 10.1038/S41375-024-02336-1 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus